Recombinant human stem cell factor - SinobiomedAlternative Names: rh-SCF
Latest Information Update: 26 Jan 2011
At a glance
- Originator Sinobiomed
- Class Antiasthmatics; Antineoplastics; Stem cell factors
- Mechanism of Action Stem cell modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Haematological disorders
Most Recent Events
- 08 Sep 2008 Phase-I clinical trials in Haematological disorders in China (unspecified route)